WearME-Pro Patch for COPD

(WearME-Pro Trial)

This trial tests a new wearable patch system designed to help people with COPD monitor their lung function at home. The goal is to assess the safety and ease of use of the WearME-Pro Patch System and its effectiveness in tracking lung health compared to a handheld device. Participants will use the patch with either guided training or self-guided instructions. This trial suits those who have managed COPD for at least two months without changing their medication and can perform daily tasks like sitting upright and using a simple device. As an unphased trial, this study offers a unique opportunity to contribute to innovative research that could enhance COPD management for many.

The trial does not specify that you need to stop taking your current medications. However, you must be on stable maintenance therapy for at least 2 months without changes in medication class or dose.

Previous studies have tested the WearME-Pro patch system for safety and ease of use in monitoring adults with COPD, a lung disease that makes breathing difficult. Research has shown that the device is generally well-tolerated, with no major side effects reported. The patch system includes wearable technology that tracks breathing and lung function. It has monitored the severity of COPD and respiratory health, showing promising results without safety concerns. Although the patch remains under study, these findings suggest it is safe for home use.¹²³⁴⁵

Researchers are excited about the WearME-Pro Patch for COPD because it offers a novel approach to monitoring lung function at home. Unlike traditional COPD treatments that primarily involve inhalers and medications to manage symptoms, this patch system provides a non-invasive way to continuously assess lung health. Participants use the patch alongside daily handheld spirometry, potentially leading to better adherence and a more comprehensive understanding of disease management. By evaluating usability and predictive accuracy, this trial aims to find out if the patch can effectively complement existing therapies and improve patient outcomes.

Research has shown that the WearME-Pro patch system holds promise for monitoring COPD (chronic obstructive pulmonary disease) at home. In this trial, participants will use the WearME-Pro patch system in one of two ways: with guided training or through self-guided instructions. Studies have found that the system effectively tracks breathing by comparing its data to standard lung function tests. Early results suggest that the system can accurately detect breathing patterns and changes, such as wheezing, using advanced technology. Additionally, the Mayo Clinic found that data from the wearable device could predict patients' likelihood of participating in remote rehab programs for COPD. These findings highlight the potential of the WearME-Pro patch to aid in the ongoing monitoring and management of COPD.¹²³⁴⁶